Acuta Capital Partners as of March 31, 2024
Portfolio Holdings for Acuta Capital Partners
Acuta Capital Partners holds 33 positions in its portfolio as reported in the March 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ocular Therapeutix (OCUL) | 15.6 | $24M | 2.6M | 9.10 | |
| Praxis Precision Medicines I (PRAX) | 6.4 | $9.9M | 162k | 61.02 | |
| Mersana Therapeutics (MRSN) | 6.3 | $9.7M | 2.2M | 4.48 | |
| Taysha Gene Therapies Com Shs (TSHA) | 6.2 | $9.6M | 3.3M | 2.87 | |
| Rocket Pharmaceuticals (RCKT) | 5.7 | $8.8M | 327k | 26.94 | |
| Sarepta Therapeutics (SRPT) | 5.4 | $8.3M | 64k | 129.46 | |
| Vaxcyte (PCVX) | 4.7 | $7.2M | 105k | 68.31 | |
| Enliven Therapeutics (ELVN) | 4.5 | $7.0M | 396k | 17.59 | |
| Tourmaline Bio (TRML) | 3.9 | $6.0M | 261k | 22.90 | |
| Applied Therapeutics (APLT) | 3.5 | $5.4M | 792k | 6.80 | |
| Dyne Therapeutics (DYN) | 3.4 | $5.2M | 185k | 28.39 | |
| Disc Medicine (IRON) | 3.1 | $4.8M | 77k | 62.26 | |
| Revolution Medicines (RVMD) | 3.0 | $4.6M | 144k | 32.23 | |
| Celldex Therapeutics Com New (CLDX) | 3.0 | $4.6M | 109k | 41.97 | |
| Aadi Bioscience (AADI) | 2.8 | $4.3M | 1.8M | 2.34 | |
| Hillevax (HLVX) | 2.7 | $4.2M | 251k | 16.63 | |
| Crinetics Pharmaceuticals In (CRNX) | 2.4 | $3.7M | 78k | 46.81 | |
| Miragen Therapeutics (VRDN) | 2.3 | $3.5M | 199k | 17.51 | |
| Terns Pharmaceuticals (TERN) | 2.0 | $3.1M | 465k | 6.56 | |
| Immunovant (IMVT) | 1.9 | $3.0M | 92k | 32.31 | |
| Verastem Com New (VSTM) | 1.6 | $2.4M | 207k | 11.80 | |
| Arcellx Common Stock (ACLX) | 1.6 | $2.4M | 35k | 69.55 | |
| Kura Oncology (KURA) | 1.2 | $1.9M | 90k | 21.33 | |
| Insmed Com Par $.01 (INSM) | 1.1 | $1.7M | 62k | 27.13 | |
| Agios Pharmaceuticals (AGIO) | 1.0 | $1.6M | 55k | 29.24 | |
| Oric Pharmaceuticals (ORIC) | 0.9 | $1.4M | 104k | 13.75 | |
| Mereo Biopharma Group Spon Ads (MREO) | 0.9 | $1.3M | 398k | 3.30 | |
| Lyra Therapeutics (LYRA) | 0.7 | $1.1M | 173k | 6.22 | |
| Leap Therapeutics Com New (LPTX) | 0.6 | $942k | 354k | 2.66 | |
| Ultragenyx Pharmaceutical (RARE) | 0.6 | $934k | 20k | 46.69 | |
| Intra Cellular Therapies (ITCI) | 0.6 | $920k | 13k | 69.20 | |
| Cellectar Biosciences Com New (CLRB) | 0.4 | $571k | 144k | 3.98 | |
| Nuvation Bio *w Exp 07/07/2027 (NUVB.WS) | 0.0 | $28k | 91k | 0.30 |
